These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31750247)

  • 1. Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
    Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
    Front Oncol; 2019; 9():1156. PubMed ID: 31750247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.
    Hu X; Zhu H; Shen Y; Zhang X; He X; Xu X
    Front Oncol; 2021; 11():696705. PubMed ID: 34367979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
    Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
    Front Oncol; 2020; 10():277. PubMed ID: 32195187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.
    Lai Y; Huang H; Abudoureyimu M; Lin X; Tian C; Wang T; Chu X; Wang R
    Am J Cancer Res; 2020; 10(12):4066-4084. PubMed ID: 33414986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance.
    Awan FM; Naz A; Obaid A; Ikram A; Ali A; Ahmad J; Naveed AK; Janjua HA
    Sci Rep; 2017 Sep; 7(1):11448. PubMed ID: 28904393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.
    Wang W; Hao LP; Song H; Chu XY; Wang R
    Front Oncol; 2022; 12():790916. PubMed ID: 35280805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma.
    Manna D; Sarkar D
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.
    Jesenko T; Brezar SK; Cemazar M; Biasin A; Tierno D; Scaggiante B; Grassi M; Grassi C; Dapas B; Truong NH; Abrami M; Zanconati F; Bonazza D; Rizzolio F; Parisi S; Pastorin G; Grassi G
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma.
    Wang D; Chen F; Zeng T; Tang Q; Chen B; Chen L; Dong Y; Li X
    Genes Dis; 2021 Mar; 8(2):157-167. PubMed ID: 33997162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
    Wong CM; Tsang FH; Ng IO
    Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks.
    Kanthaje S; Makol A; Chakraborti A
    Hepatol Res; 2018 Jan; 48(1):5-14. PubMed ID: 29055114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma.
    Chen T
    J Hepatocell Carcinoma; 2022; 9():1029-1040. PubMed ID: 36132427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging landscape of long non-coding RNAs in hepatocellular carcinoma.
    Zhu Y; Xu G; Han C; Xing G
    Int J Clin Exp Pathol; 2021; 14(9):920-937. PubMed ID: 34646411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs: critical players in hepatocellular carcinoma.
    Sun J; Bie B; Zhang S; Yang J; Li Z
    Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.
    Pollutri D; Patrizi C; Marinelli S; Giovannini C; Trombetta E; Giannone FA; Baldassarre M; Quarta S; Vandewynckel YP; Vandierendonck A; Van Vlierberghe H; Porretti L; Negrini M; Bolondi L; Gramantieri L; Fornari F
    Cell Death Dis; 2018 Jan; 9(1):4. PubMed ID: 29305580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.